Global Endometriosis Market Research Report 2024(Status and Outlook)
Report Overview:
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.
The Global Endometriosis Market Size was estimated at USD 1539.39 million in 2023 and is projected to reach USD 1673.31 million by 2029, exhibiting a CAGR of 1.40% during the forecast period.
This report provides a deep insight into the global Endometriosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Endometriosis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Endometriosis market in any manner.
Global Endometriosis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
Market Segmentation (by Type)
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Market Segmentation (by Application)
Hospital Use
Clinic Use
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endometriosis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.
The Global Endometriosis Market Size was estimated at USD 1539.39 million in 2023 and is projected to reach USD 1673.31 million by 2029, exhibiting a CAGR of 1.40% during the forecast period.
This report provides a deep insight into the global Endometriosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Endometriosis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Endometriosis market in any manner.
Global Endometriosis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
Market Segmentation (by Type)
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Market Segmentation (by Application)
Hospital Use
Clinic Use
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Endometriosis Market
- Overview of the regional outlook of the Endometriosis Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endometriosis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Endometriosis
1.2 Key Market Segments
1.2.1 Endometriosis Segment by Type
1.2.2 Endometriosis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENDOMETRIOSIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Endometriosis Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Endometriosis Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENDOMETRIOSIS MARKET COMPETITIVE LANDSCAPE
3.1 Global Endometriosis Sales by Manufacturers (2019-2024)
3.2 Global Endometriosis Revenue Market Share by Manufacturers (2019-2024)
3.3 Endometriosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Endometriosis Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Endometriosis Sales Sites, Area Served, Product Type
3.6 Endometriosis Market Competitive Situation and Trends
3.6.1 Endometriosis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Endometriosis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ENDOMETRIOSIS INDUSTRY CHAIN ANALYSIS
4.1 Endometriosis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENDOMETRIOSIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ENDOMETRIOSIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Endometriosis Sales Market Share by Type (2019-2024)
6.3 Global Endometriosis Market Size Market Share by Type (2019-2024)
6.4 Global Endometriosis Price by Type (2019-2024)
7 ENDOMETRIOSIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Endometriosis Market Sales by Application (2019-2024)
7.3 Global Endometriosis Market Size (M USD) by Application (2019-2024)
7.4 Global Endometriosis Sales Growth Rate by Application (2019-2024)
8 ENDOMETRIOSIS MARKET SEGMENTATION BY REGION
8.1 Global Endometriosis Sales by Region
8.1.1 Global Endometriosis Sales by Region
8.1.2 Global Endometriosis Sales Market Share by Region
8.2 North America
8.2.1 North America Endometriosis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Endometriosis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Endometriosis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Endometriosis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Endometriosis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Endometriosis Basic Information
9.1.2 AbbVie Endometriosis Product Overview
9.1.3 AbbVie Endometriosis Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Endometriosis SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Endometriosis Basic Information
9.2.2 AstraZeneca Endometriosis Product Overview
9.2.3 AstraZeneca Endometriosis Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Endometriosis SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bayer HealthCare
9.3.1 Bayer HealthCare Endometriosis Basic Information
9.3.2 Bayer HealthCare Endometriosis Product Overview
9.3.3 Bayer HealthCare Endometriosis Product Market Performance
9.3.4 Bayer HealthCare Endometriosis SWOT Analysis
9.3.5 Bayer HealthCare Business Overview
9.3.6 Bayer HealthCare Recent Developments
9.4 Pfizer
9.4.1 Pfizer Endometriosis Basic Information
9.4.2 Pfizer Endometriosis Product Overview
9.4.3 Pfizer Endometriosis Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Addex Therapeutics
9.5.1 Addex Therapeutics Endometriosis Basic Information
9.5.2 Addex Therapeutics Endometriosis Product Overview
9.5.3 Addex Therapeutics Endometriosis Product Market Performance
9.5.4 Addex Therapeutics Business Overview
9.5.5 Addex Therapeutics Recent Developments
9.6 Astellas Pharma
9.6.1 Astellas Pharma Endometriosis Basic Information
9.6.2 Astellas Pharma Endometriosis Product Overview
9.6.3 Astellas Pharma Endometriosis Product Market Performance
9.6.4 Astellas Pharma Business Overview
9.6.5 Astellas Pharma Recent Developments
9.7 Debiopharm
9.7.1 Debiopharm Endometriosis Basic Information
9.7.2 Debiopharm Endometriosis Product Overview
9.7.3 Debiopharm Endometriosis Product Market Performance
9.7.4 Debiopharm Business Overview
9.7.5 Debiopharm Recent Developments
9.8 ElexoPharm
9.8.1 ElexoPharm Endometriosis Basic Information
9.8.2 ElexoPharm Endometriosis Product Overview
9.8.3 ElexoPharm Endometriosis Product Market Performance
9.8.4 ElexoPharm Business Overview
9.8.5 ElexoPharm Recent Developments
9.9 EndoCeutics
9.9.1 EndoCeutics Endometriosis Basic Information
9.9.2 EndoCeutics Endometriosis Product Overview
9.9.3 EndoCeutics Endometriosis Product Market Performance
9.9.4 EndoCeutics Business Overview
9.9.5 EndoCeutics Recent Developments
9.10 Euroscreen
9.10.1 Euroscreen Endometriosis Basic Information
9.10.2 Euroscreen Endometriosis Product Overview
9.10.3 Euroscreen Endometriosis Product Market Performance
9.10.4 Euroscreen Business Overview
9.10.5 Euroscreen Recent Developments
9.11 Forendo Pharma
9.11.1 Forendo Pharma Endometriosis Basic Information
9.11.2 Forendo Pharma Endometriosis Product Overview
9.11.3 Forendo Pharma Endometriosis Product Market Performance
9.11.4 Forendo Pharma Business Overview
9.11.5 Forendo Pharma Recent Developments
9.12 Kissei Pharmaceutical
9.12.1 Kissei Pharmaceutical Endometriosis Basic Information
9.12.2 Kissei Pharmaceutical Endometriosis Product Overview
9.12.3 Kissei Pharmaceutical Endometriosis Product Market Performance
9.12.4 Kissei Pharmaceutical Business Overview
9.12.5 Kissei Pharmaceutical Recent Developments
9.13 Neurocrine Biosciences
9.13.1 Neurocrine Biosciences Endometriosis Basic Information
9.13.2 Neurocrine Biosciences Endometriosis Product Overview
9.13.3 Neurocrine Biosciences Endometriosis Product Market Performance
9.13.4 Neurocrine Biosciences Business Overview
9.13.5 Neurocrine Biosciences Recent Developments
9.14 Nippon Shinyaku
9.14.1 Nippon Shinyaku Endometriosis Basic Information
9.14.2 Nippon Shinyaku Endometriosis Product Overview
9.14.3 Nippon Shinyaku Endometriosis Product Market Performance
9.14.4 Nippon Shinyaku Business Overview
9.14.5 Nippon Shinyaku Recent Developments
9.15 Takeda
9.15.1 Takeda Endometriosis Basic Information
9.15.2 Takeda Endometriosis Product Overview
9.15.3 Takeda Endometriosis Product Market Performance
9.15.4 Takeda Business Overview
9.15.5 Takeda Recent Developments
9.16 Bayer AG
9.16.1 Bayer AG Endometriosis Basic Information
9.16.2 Bayer AG Endometriosis Product Overview
9.16.3 Bayer AG Endometriosis Product Market Performance
9.16.4 Bayer AG Business Overview
9.16.5 Bayer AG Recent Developments
9.17 Neurocrine Biosciences
9.17.1 Neurocrine Biosciences Endometriosis Basic Information
9.17.2 Neurocrine Biosciences Endometriosis Product Overview
9.17.3 Neurocrine Biosciences Endometriosis Product Market Performance
9.17.4 Neurocrine Biosciences Business Overview
9.17.5 Neurocrine Biosciences Recent Developments
10 ENDOMETRIOSIS MARKET FORECAST BY REGION
10.1 Global Endometriosis Market Size Forecast
10.2 Global Endometriosis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Endometriosis Market Size Forecast by Country
10.2.3 Asia Pacific Endometriosis Market Size Forecast by Region
10.2.4 South America Endometriosis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Endometriosis by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Endometriosis Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Endometriosis by Type (2025-2030)
11.1.2 Global Endometriosis Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Endometriosis by Type (2025-2030)
11.2 Global Endometriosis Market Forecast by Application (2025-2030)
11.2.1 Global Endometriosis Sales (Kilotons) Forecast by Application
11.2.2 Global Endometriosis Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Endometriosis
1.2 Key Market Segments
1.2.1 Endometriosis Segment by Type
1.2.2 Endometriosis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENDOMETRIOSIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Endometriosis Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Endometriosis Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENDOMETRIOSIS MARKET COMPETITIVE LANDSCAPE
3.1 Global Endometriosis Sales by Manufacturers (2019-2024)
3.2 Global Endometriosis Revenue Market Share by Manufacturers (2019-2024)
3.3 Endometriosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Endometriosis Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Endometriosis Sales Sites, Area Served, Product Type
3.6 Endometriosis Market Competitive Situation and Trends
3.6.1 Endometriosis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Endometriosis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ENDOMETRIOSIS INDUSTRY CHAIN ANALYSIS
4.1 Endometriosis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENDOMETRIOSIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ENDOMETRIOSIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Endometriosis Sales Market Share by Type (2019-2024)
6.3 Global Endometriosis Market Size Market Share by Type (2019-2024)
6.4 Global Endometriosis Price by Type (2019-2024)
7 ENDOMETRIOSIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Endometriosis Market Sales by Application (2019-2024)
7.3 Global Endometriosis Market Size (M USD) by Application (2019-2024)
7.4 Global Endometriosis Sales Growth Rate by Application (2019-2024)
8 ENDOMETRIOSIS MARKET SEGMENTATION BY REGION
8.1 Global Endometriosis Sales by Region
8.1.1 Global Endometriosis Sales by Region
8.1.2 Global Endometriosis Sales Market Share by Region
8.2 North America
8.2.1 North America Endometriosis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Endometriosis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Endometriosis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Endometriosis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Endometriosis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Endometriosis Basic Information
9.1.2 AbbVie Endometriosis Product Overview
9.1.3 AbbVie Endometriosis Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Endometriosis SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Endometriosis Basic Information
9.2.2 AstraZeneca Endometriosis Product Overview
9.2.3 AstraZeneca Endometriosis Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Endometriosis SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bayer HealthCare
9.3.1 Bayer HealthCare Endometriosis Basic Information
9.3.2 Bayer HealthCare Endometriosis Product Overview
9.3.3 Bayer HealthCare Endometriosis Product Market Performance
9.3.4 Bayer HealthCare Endometriosis SWOT Analysis
9.3.5 Bayer HealthCare Business Overview
9.3.6 Bayer HealthCare Recent Developments
9.4 Pfizer
9.4.1 Pfizer Endometriosis Basic Information
9.4.2 Pfizer Endometriosis Product Overview
9.4.3 Pfizer Endometriosis Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Addex Therapeutics
9.5.1 Addex Therapeutics Endometriosis Basic Information
9.5.2 Addex Therapeutics Endometriosis Product Overview
9.5.3 Addex Therapeutics Endometriosis Product Market Performance
9.5.4 Addex Therapeutics Business Overview
9.5.5 Addex Therapeutics Recent Developments
9.6 Astellas Pharma
9.6.1 Astellas Pharma Endometriosis Basic Information
9.6.2 Astellas Pharma Endometriosis Product Overview
9.6.3 Astellas Pharma Endometriosis Product Market Performance
9.6.4 Astellas Pharma Business Overview
9.6.5 Astellas Pharma Recent Developments
9.7 Debiopharm
9.7.1 Debiopharm Endometriosis Basic Information
9.7.2 Debiopharm Endometriosis Product Overview
9.7.3 Debiopharm Endometriosis Product Market Performance
9.7.4 Debiopharm Business Overview
9.7.5 Debiopharm Recent Developments
9.8 ElexoPharm
9.8.1 ElexoPharm Endometriosis Basic Information
9.8.2 ElexoPharm Endometriosis Product Overview
9.8.3 ElexoPharm Endometriosis Product Market Performance
9.8.4 ElexoPharm Business Overview
9.8.5 ElexoPharm Recent Developments
9.9 EndoCeutics
9.9.1 EndoCeutics Endometriosis Basic Information
9.9.2 EndoCeutics Endometriosis Product Overview
9.9.3 EndoCeutics Endometriosis Product Market Performance
9.9.4 EndoCeutics Business Overview
9.9.5 EndoCeutics Recent Developments
9.10 Euroscreen
9.10.1 Euroscreen Endometriosis Basic Information
9.10.2 Euroscreen Endometriosis Product Overview
9.10.3 Euroscreen Endometriosis Product Market Performance
9.10.4 Euroscreen Business Overview
9.10.5 Euroscreen Recent Developments
9.11 Forendo Pharma
9.11.1 Forendo Pharma Endometriosis Basic Information
9.11.2 Forendo Pharma Endometriosis Product Overview
9.11.3 Forendo Pharma Endometriosis Product Market Performance
9.11.4 Forendo Pharma Business Overview
9.11.5 Forendo Pharma Recent Developments
9.12 Kissei Pharmaceutical
9.12.1 Kissei Pharmaceutical Endometriosis Basic Information
9.12.2 Kissei Pharmaceutical Endometriosis Product Overview
9.12.3 Kissei Pharmaceutical Endometriosis Product Market Performance
9.12.4 Kissei Pharmaceutical Business Overview
9.12.5 Kissei Pharmaceutical Recent Developments
9.13 Neurocrine Biosciences
9.13.1 Neurocrine Biosciences Endometriosis Basic Information
9.13.2 Neurocrine Biosciences Endometriosis Product Overview
9.13.3 Neurocrine Biosciences Endometriosis Product Market Performance
9.13.4 Neurocrine Biosciences Business Overview
9.13.5 Neurocrine Biosciences Recent Developments
9.14 Nippon Shinyaku
9.14.1 Nippon Shinyaku Endometriosis Basic Information
9.14.2 Nippon Shinyaku Endometriosis Product Overview
9.14.3 Nippon Shinyaku Endometriosis Product Market Performance
9.14.4 Nippon Shinyaku Business Overview
9.14.5 Nippon Shinyaku Recent Developments
9.15 Takeda
9.15.1 Takeda Endometriosis Basic Information
9.15.2 Takeda Endometriosis Product Overview
9.15.3 Takeda Endometriosis Product Market Performance
9.15.4 Takeda Business Overview
9.15.5 Takeda Recent Developments
9.16 Bayer AG
9.16.1 Bayer AG Endometriosis Basic Information
9.16.2 Bayer AG Endometriosis Product Overview
9.16.3 Bayer AG Endometriosis Product Market Performance
9.16.4 Bayer AG Business Overview
9.16.5 Bayer AG Recent Developments
9.17 Neurocrine Biosciences
9.17.1 Neurocrine Biosciences Endometriosis Basic Information
9.17.2 Neurocrine Biosciences Endometriosis Product Overview
9.17.3 Neurocrine Biosciences Endometriosis Product Market Performance
9.17.4 Neurocrine Biosciences Business Overview
9.17.5 Neurocrine Biosciences Recent Developments
10 ENDOMETRIOSIS MARKET FORECAST BY REGION
10.1 Global Endometriosis Market Size Forecast
10.2 Global Endometriosis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Endometriosis Market Size Forecast by Country
10.2.3 Asia Pacific Endometriosis Market Size Forecast by Region
10.2.4 South America Endometriosis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Endometriosis by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Endometriosis Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Endometriosis by Type (2025-2030)
11.1.2 Global Endometriosis Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Endometriosis by Type (2025-2030)
11.2 Global Endometriosis Market Forecast by Application (2025-2030)
11.2.1 Global Endometriosis Sales (Kilotons) Forecast by Application
11.2.2 Global Endometriosis Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Endometriosis Market Size Comparison by Region (M USD)
Table 5. Global Endometriosis Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Endometriosis Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Endometriosis Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Endometriosis Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis as of 2022)
Table 10. Global Market Endometriosis Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Endometriosis Sales Sites and Area Served
Table 12. Manufacturers Endometriosis Product Type
Table 13. Global Endometriosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Endometriosis
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Endometriosis Market Challenges
Table 22. Global Endometriosis Sales by Type (Kilotons)
Table 23. Global Endometriosis Market Size by Type (M USD)
Table 24. Global Endometriosis Sales (Kilotons) by Type (2019-2024)
Table 25. Global Endometriosis Sales Market Share by Type (2019-2024)
Table 26. Global Endometriosis Market Size (M USD) by Type (2019-2024)
Table 27. Global Endometriosis Market Size Share by Type (2019-2024)
Table 28. Global Endometriosis Price (USD/Ton) by Type (2019-2024)
Table 29. Global Endometriosis Sales (Kilotons) by Application
Table 30. Global Endometriosis Market Size by Application
Table 31. Global Endometriosis Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Endometriosis Sales Market Share by Application (2019-2024)
Table 33. Global Endometriosis Sales by Application (2019-2024) & (M USD)
Table 34. Global Endometriosis Market Share by Application (2019-2024)
Table 35. Global Endometriosis Sales Growth Rate by Application (2019-2024)
Table 36. Global Endometriosis Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Endometriosis Sales Market Share by Region (2019-2024)
Table 38. North America Endometriosis Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Endometriosis Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Endometriosis Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Endometriosis Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Endometriosis Sales by Region (2019-2024) & (Kilotons)
Table 43. AbbVie Endometriosis Basic Information
Table 44. AbbVie Endometriosis Product Overview
Table 45. AbbVie Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Endometriosis SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. AstraZeneca Endometriosis Basic Information
Table 50. AstraZeneca Endometriosis Product Overview
Table 51. AstraZeneca Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Endometriosis SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Bayer HealthCare Endometriosis Basic Information
Table 56. Bayer HealthCare Endometriosis Product Overview
Table 57. Bayer HealthCare Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bayer HealthCare Endometriosis SWOT Analysis
Table 59. Bayer HealthCare Business Overview
Table 60. Bayer HealthCare Recent Developments
Table 61. Pfizer Endometriosis Basic Information
Table 62. Pfizer Endometriosis Product Overview
Table 63. Pfizer Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Addex Therapeutics Endometriosis Basic Information
Table 67. Addex Therapeutics Endometriosis Product Overview
Table 68. Addex Therapeutics Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Addex Therapeutics Business Overview
Table 70. Addex Therapeutics Recent Developments
Table 71. Astellas Pharma Endometriosis Basic Information
Table 72. Astellas Pharma Endometriosis Product Overview
Table 73. Astellas Pharma Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Astellas Pharma Business Overview
Table 75. Astellas Pharma Recent Developments
Table 76. Debiopharm Endometriosis Basic Information
Table 77. Debiopharm Endometriosis Product Overview
Table 78. Debiopharm Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Debiopharm Business Overview
Table 80. Debiopharm Recent Developments
Table 81. ElexoPharm Endometriosis Basic Information
Table 82. ElexoPharm Endometriosis Product Overview
Table 83. ElexoPharm Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ElexoPharm Business Overview
Table 85. ElexoPharm Recent Developments
Table 86. EndoCeutics Endometriosis Basic Information
Table 87. EndoCeutics Endometriosis Product Overview
Table 88. EndoCeutics Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. EndoCeutics Business Overview
Table 90. EndoCeutics Recent Developments
Table 91. Euroscreen Endometriosis Basic Information
Table 92. Euroscreen Endometriosis Product Overview
Table 93. Euroscreen Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Euroscreen Business Overview
Table 95. Euroscreen Recent Developments
Table 96. Forendo Pharma Endometriosis Basic Information
Table 97. Forendo Pharma Endometriosis Product Overview
Table 98. Forendo Pharma Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Forendo Pharma Business Overview
Table 100. Forendo Pharma Recent Developments
Table 101. Kissei Pharmaceutical Endometriosis Basic Information
Table 102. Kissei Pharmaceutical Endometriosis Product Overview
Table 103. Kissei Pharmaceutical Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Kissei Pharmaceutical Business Overview
Table 105. Kissei Pharmaceutical Recent Developments
Table 106. Neurocrine Biosciences Endometriosis Basic Information
Table 107. Neurocrine Biosciences Endometriosis Product Overview
Table 108. Neurocrine Biosciences Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Neurocrine Biosciences Business Overview
Table 110. Neurocrine Biosciences Recent Developments
Table 111. Nippon Shinyaku Endometriosis Basic Information
Table 112. Nippon Shinyaku Endometriosis Product Overview
Table 113. Nippon Shinyaku Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Nippon Shinyaku Business Overview
Table 115. Nippon Shinyaku Recent Developments
Table 116. Takeda Endometriosis Basic Information
Table 117. Takeda Endometriosis Product Overview
Table 118. Takeda Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Takeda Business Overview
Table 120. Takeda Recent Developments
Table 121. Bayer AG Endometriosis Basic Information
Table 122. Bayer AG Endometriosis Product Overview
Table 123. Bayer AG Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Bayer AG Business Overview
Table 125. Bayer AG Recent Developments
Table 126. Neurocrine Biosciences Endometriosis Basic Information
Table 127. Neurocrine Biosciences Endometriosis Product Overview
Table 128. Neurocrine Biosciences Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Neurocrine Biosciences Business Overview
Table 130. Neurocrine Biosciences Recent Developments
Table 131. Global Endometriosis Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Endometriosis Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Endometriosis Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Endometriosis Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Endometriosis Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Endometriosis Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Endometriosis Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Endometriosis Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Endometriosis Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Endometriosis Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Endometriosis Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Endometriosis Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Endometriosis Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Endometriosis Market Size Comparison by Region (M USD)
Table 5. Global Endometriosis Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Endometriosis Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Endometriosis Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Endometriosis Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis as of 2022)
Table 10. Global Market Endometriosis Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Endometriosis Sales Sites and Area Served
Table 12. Manufacturers Endometriosis Product Type
Table 13. Global Endometriosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Endometriosis
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Endometriosis Market Challenges
Table 22. Global Endometriosis Sales by Type (Kilotons)
Table 23. Global Endometriosis Market Size by Type (M USD)
Table 24. Global Endometriosis Sales (Kilotons) by Type (2019-2024)
Table 25. Global Endometriosis Sales Market Share by Type (2019-2024)
Table 26. Global Endometriosis Market Size (M USD) by Type (2019-2024)
Table 27. Global Endometriosis Market Size Share by Type (2019-2024)
Table 28. Global Endometriosis Price (USD/Ton) by Type (2019-2024)
Table 29. Global Endometriosis Sales (Kilotons) by Application
Table 30. Global Endometriosis Market Size by Application
Table 31. Global Endometriosis Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Endometriosis Sales Market Share by Application (2019-2024)
Table 33. Global Endometriosis Sales by Application (2019-2024) & (M USD)
Table 34. Global Endometriosis Market Share by Application (2019-2024)
Table 35. Global Endometriosis Sales Growth Rate by Application (2019-2024)
Table 36. Global Endometriosis Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Endometriosis Sales Market Share by Region (2019-2024)
Table 38. North America Endometriosis Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Endometriosis Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Endometriosis Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Endometriosis Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Endometriosis Sales by Region (2019-2024) & (Kilotons)
Table 43. AbbVie Endometriosis Basic Information
Table 44. AbbVie Endometriosis Product Overview
Table 45. AbbVie Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Endometriosis SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. AstraZeneca Endometriosis Basic Information
Table 50. AstraZeneca Endometriosis Product Overview
Table 51. AstraZeneca Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Endometriosis SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Bayer HealthCare Endometriosis Basic Information
Table 56. Bayer HealthCare Endometriosis Product Overview
Table 57. Bayer HealthCare Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bayer HealthCare Endometriosis SWOT Analysis
Table 59. Bayer HealthCare Business Overview
Table 60. Bayer HealthCare Recent Developments
Table 61. Pfizer Endometriosis Basic Information
Table 62. Pfizer Endometriosis Product Overview
Table 63. Pfizer Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Addex Therapeutics Endometriosis Basic Information
Table 67. Addex Therapeutics Endometriosis Product Overview
Table 68. Addex Therapeutics Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Addex Therapeutics Business Overview
Table 70. Addex Therapeutics Recent Developments
Table 71. Astellas Pharma Endometriosis Basic Information
Table 72. Astellas Pharma Endometriosis Product Overview
Table 73. Astellas Pharma Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Astellas Pharma Business Overview
Table 75. Astellas Pharma Recent Developments
Table 76. Debiopharm Endometriosis Basic Information
Table 77. Debiopharm Endometriosis Product Overview
Table 78. Debiopharm Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Debiopharm Business Overview
Table 80. Debiopharm Recent Developments
Table 81. ElexoPharm Endometriosis Basic Information
Table 82. ElexoPharm Endometriosis Product Overview
Table 83. ElexoPharm Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ElexoPharm Business Overview
Table 85. ElexoPharm Recent Developments
Table 86. EndoCeutics Endometriosis Basic Information
Table 87. EndoCeutics Endometriosis Product Overview
Table 88. EndoCeutics Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. EndoCeutics Business Overview
Table 90. EndoCeutics Recent Developments
Table 91. Euroscreen Endometriosis Basic Information
Table 92. Euroscreen Endometriosis Product Overview
Table 93. Euroscreen Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Euroscreen Business Overview
Table 95. Euroscreen Recent Developments
Table 96. Forendo Pharma Endometriosis Basic Information
Table 97. Forendo Pharma Endometriosis Product Overview
Table 98. Forendo Pharma Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Forendo Pharma Business Overview
Table 100. Forendo Pharma Recent Developments
Table 101. Kissei Pharmaceutical Endometriosis Basic Information
Table 102. Kissei Pharmaceutical Endometriosis Product Overview
Table 103. Kissei Pharmaceutical Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Kissei Pharmaceutical Business Overview
Table 105. Kissei Pharmaceutical Recent Developments
Table 106. Neurocrine Biosciences Endometriosis Basic Information
Table 107. Neurocrine Biosciences Endometriosis Product Overview
Table 108. Neurocrine Biosciences Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Neurocrine Biosciences Business Overview
Table 110. Neurocrine Biosciences Recent Developments
Table 111. Nippon Shinyaku Endometriosis Basic Information
Table 112. Nippon Shinyaku Endometriosis Product Overview
Table 113. Nippon Shinyaku Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Nippon Shinyaku Business Overview
Table 115. Nippon Shinyaku Recent Developments
Table 116. Takeda Endometriosis Basic Information
Table 117. Takeda Endometriosis Product Overview
Table 118. Takeda Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Takeda Business Overview
Table 120. Takeda Recent Developments
Table 121. Bayer AG Endometriosis Basic Information
Table 122. Bayer AG Endometriosis Product Overview
Table 123. Bayer AG Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Bayer AG Business Overview
Table 125. Bayer AG Recent Developments
Table 126. Neurocrine Biosciences Endometriosis Basic Information
Table 127. Neurocrine Biosciences Endometriosis Product Overview
Table 128. Neurocrine Biosciences Endometriosis Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Neurocrine Biosciences Business Overview
Table 130. Neurocrine Biosciences Recent Developments
Table 131. Global Endometriosis Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Endometriosis Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Endometriosis Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Endometriosis Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Endometriosis Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Endometriosis Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Endometriosis Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Endometriosis Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Endometriosis Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Endometriosis Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Endometriosis Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Endometriosis Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Endometriosis Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Endometriosis Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Endometriosis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Endometriosis Market Size (M USD), 2019-2030
Figure 5. Global Endometriosis Market Size (M USD) (2019-2030)
Figure 6. Global Endometriosis Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Endometriosis Market Size by Country (M USD)
Figure 11. Endometriosis Sales Share by Manufacturers in 2023
Figure 12. Global Endometriosis Revenue Share by Manufacturers in 2023
Figure 13. Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Endometriosis Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Endometriosis Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Endometriosis Market Share by Type
Figure 18. Sales Market Share of Endometriosis by Type (2019-2024)
Figure 19. Sales Market Share of Endometriosis by Type in 2023
Figure 20. Market Size Share of Endometriosis by Type (2019-2024)
Figure 21. Market Size Market Share of Endometriosis by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Endometriosis Market Share by Application
Figure 24. Global Endometriosis Sales Market Share by Application (2019-2024)
Figure 25. Global Endometriosis Sales Market Share by Application in 2023
Figure 26. Global Endometriosis Market Share by Application (2019-2024)
Figure 27. Global Endometriosis Market Share by Application in 2023
Figure 28. Global Endometriosis Sales Growth Rate by Application (2019-2024)
Figure 29. Global Endometriosis Sales Market Share by Region (2019-2024)
Figure 30. North America Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Endometriosis Sales Market Share by Country in 2023
Figure 32. U.S. Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Endometriosis Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Endometriosis Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Endometriosis Sales Market Share by Country in 2023
Figure 37. Germany Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Endometriosis Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Endometriosis Sales Market Share by Region in 2023
Figure 44. China Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Endometriosis Sales and Growth Rate (Kilotons)
Figure 50. South America Endometriosis Sales Market Share by Country in 2023
Figure 51. Brazil Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Endometriosis Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Endometriosis Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Endometriosis Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Endometriosis Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Endometriosis Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Endometriosis Market Share Forecast by Type (2025-2030)
Figure 65. Global Endometriosis Sales Forecast by Application (2025-2030)
Figure 66. Global Endometriosis Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Endometriosis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Endometriosis Market Size (M USD), 2019-2030
Figure 5. Global Endometriosis Market Size (M USD) (2019-2030)
Figure 6. Global Endometriosis Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Endometriosis Market Size by Country (M USD)
Figure 11. Endometriosis Sales Share by Manufacturers in 2023
Figure 12. Global Endometriosis Revenue Share by Manufacturers in 2023
Figure 13. Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Endometriosis Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Endometriosis Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Endometriosis Market Share by Type
Figure 18. Sales Market Share of Endometriosis by Type (2019-2024)
Figure 19. Sales Market Share of Endometriosis by Type in 2023
Figure 20. Market Size Share of Endometriosis by Type (2019-2024)
Figure 21. Market Size Market Share of Endometriosis by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Endometriosis Market Share by Application
Figure 24. Global Endometriosis Sales Market Share by Application (2019-2024)
Figure 25. Global Endometriosis Sales Market Share by Application in 2023
Figure 26. Global Endometriosis Market Share by Application (2019-2024)
Figure 27. Global Endometriosis Market Share by Application in 2023
Figure 28. Global Endometriosis Sales Growth Rate by Application (2019-2024)
Figure 29. Global Endometriosis Sales Market Share by Region (2019-2024)
Figure 30. North America Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Endometriosis Sales Market Share by Country in 2023
Figure 32. U.S. Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Endometriosis Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Endometriosis Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Endometriosis Sales Market Share by Country in 2023
Figure 37. Germany Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Endometriosis Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Endometriosis Sales Market Share by Region in 2023
Figure 44. China Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Endometriosis Sales and Growth Rate (Kilotons)
Figure 50. South America Endometriosis Sales Market Share by Country in 2023
Figure 51. Brazil Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Endometriosis Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Endometriosis Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Endometriosis Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Endometriosis Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Endometriosis Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Endometriosis Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Endometriosis Market Share Forecast by Type (2025-2030)
Figure 65. Global Endometriosis Sales Forecast by Application (2025-2030)
Figure 66. Global Endometriosis Market Share Forecast by Application (2025-2030)
